Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

1. Sateia MJ, ed. International Classification of Sleep Disorders: diagnostic and coding manual, 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.

2. Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology. 2002;58(12):1826 1833.

3. National Sleep Foundation. Sleep in America Poll, 2002.

4. Johns MW. A new method of measuring sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):

540 545.

5. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10(4):431 436.

6. Rosenthal L, Roehr TA, Roth T. The sleep wake activity inventory: a self report measure of daytime sleepiness. Biol Psychiatry. 1993;34(11):810 820.

7. Richardson G, Carskadon M, Flagg W, et al. Excessive daytime sleepiness in man: multiple sleep latency measurements in narcoleptic and control subjects. Electroencepholgr Clin Neurophysiol. 1978;45(5):621 627.

8. Chua LWY, Yu NC, Golish JA, et al. Epworth sleepiness scale and the multiple sleep latency test: dilemma of the elusive link. Sleep. 1998;21(Suppl):184.

9. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol. 1998;43(1):88 97.

10. Johns MW, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep. 1997;20(10):844 849.

11. Review by the MSLT and MWT Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep. 2005;28(1):123 144.

12. Carskadon MA, Dement WC. Cumulative effects of sleep restriction on daytime sleepiness. Psychophysiology. 1981;18(2):107 113.

13. Sleep in America Poll, 2008. http://www.

14. Rosenthal L, Roehrs TA, Rosen A, Roth T. Level of sleepiness and total sleep time following various time in bed conditions. Sleep. 1993;16(3):226 232.

15. Roehrs TA, Shore E, Papineau K, Rosenthal L, Roth T. A two week sleep extension in sleepy normals. Sleep. 1996;19(7):576 582.

16. Beers T. Flexible schedules and shift work: replacing the '9 to 5' workday? Monthly Labor Rev. 2000:33 40.

17. Monk TH. Shift work. In: Kryger MH, Roth T, Dement WC, eds. Priniciples and practices of sleep medicine, 3rd ed. Philadelphia, PA: WB Saunders; 2000:602 603.

18. Akerstedt T. Sleepiness as a consequence of shift work. Sleep. 1988;11(1):17 34.

19. Budnick LD, Lerman SE, Baker TL, Jones H, Czeisler CA. Sleep and alertness in a 12 hour rotating shift work environment. J Occup Med. 1994; 36(12):1295 1300.

20. Czeisler CA, Walsh JK, Roth T, et al. Modafinil for excessive sleepiness associated with shift work sleep disorder. New Engl J Med. 2005;353(5):476 486.

21. Colton HR, Altevogt BM, eds. Sleep disorders and sleep deprivation: an unmet public health problem. Committee on Sleep Medicine and Research. The National Academies Press; 2006:55 172.

22. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003;26(2):117 126.

23. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell. 1999;98(4):437 451.

24. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98(3):365 376.

25. Mignot E, Nishino S. Emerging therapies in narcolepsy cataplexy. Sleep. 2005;28(6):754 763.

26. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39 40.

27. Black JE, Brooks SN, Nishino S. Narcolepsy and syndromes of primary excessive daytime somnolence. Sem Neurol. 2004;24(3):271 282.

28. Honda Y. Clinical features of narcolepsy: Japanese experiences. In: Honda Y, Juji T, eds. HLA in narcolepsy. Berlin: Springer Verlag; 1988:24 57.

29. Ohayon MM, Priest RG, Caulet M, Guilleminault C. Hypnogogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry. 1996; 169(4):459 467.

30. Ohayon MM, Zulley J, Guilleminault C, Smirne S. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology. 1999; 52(6):1194 1200.

31. Mamelak M, Black J, Monplaisir J, Ristanovic R.

A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep. 2004;27(7):1327 1334.

32. US Xyrem in Narcolepsy Multi center Study Group. A randomized, double blind, placebo controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep. 2002;25(1):42 49.

33. Black J. Nightly administration of sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. Sleep. 2005;28:A218(abstract).

34. Mitler MM, Aldrich MS, Koob GF, Zarcone VP. Narcolepsy and its treatment with stimulants: ASDA standards of practice. Sleep. 1994;17(4):352 371.

35. Wisor JP, Ericksson KS. Dopaminergic adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience. 2005;132(4):1027 1034.

36. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000;54(5):1166 1175.

37. Guilleminault C, Stoohs R, Clerk A, Cetel M, Maistros P. A cause of excessive daytime sleepiness:

The upper airway resistance syndrome. Chest. 1993;104(3):781 787.

38. Montplaisir J, Poirier G. HLA in disorders of excessive sleepiness without cataplexy in Canada. In: Honda Y, Juji T, eds. HLA in narcolepsy. Berlin: Springer Verlag; 1988:186.

39. Montplaisir J, De Champlain J, Young SN, et al. Narcolepsy and idiopathic hypersomnia: biogenic amines and related compounds in CSF. Neurology. 1982;32(11):1299 1302.

40. Faull KF, Guilleminault C, Berger PA, Barchas JD. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. Ann Neurol. 1983; 13(3):258 263.

41. Faull KF, Thiemann S, King RJ, Guilleminault C. Monoamine interactions in narcolepsy and hypersomnia: a preliminary report. Sleep. 1986; 9(1 Pt 2):246 249.

42. Billiard M, Dauvillies Y. Idiopathic hypersomnia. Sleep Med Rev. 2001;5(5):351 360.

43. Roth B, Nevsimalova S, Rechtschaffen A. Hypersomnia with "sleep drunkenness." Arch Gen Psychiatry. 1972;26(5):456 462.

44. Critchley M. The syndrome of hypersomnia and periodical megaphagia in the adult male (Kleine Levin): what is its natural course? Rev Neurol. 1967; 116(6):647 650.

45. Arnulf I, Zeitzer JM, File J, Farber N, Mignot E. Kleine Levin syndrome: a systematic review of 186 cases in the literature. Brain. 128(12):2763 2776.

46. Rosenow F, Kotagal P, Cohen BH, Green C, Wyllie E. Multiple sleep latency test and polysomnography in diagnosing Kleine Levin syndrome and periodic hypersomnia. J Clin Neurophysiol 2000;

47. Arias M, Crespo Iglesias JM, Perez J, et al. Klein Levin syndrome: contribution of brain SPECT in diagnosis. Rev Neurol. 2003;35(6):531 533.

48. Billiard M, Guilleminault C, Dement WC.

A menstruation linked periodic hypersomnia. Kleine Levin syndrome or a new clinical entity? Neurology. 1975;25(5):436 443.

49. Sachs C, Persson H, Hagenfeldt K. Menstruation associated periodic hypersomnia: a case study with successful treatment. Neurology. 1982;32 (12):1376 1379.

50. Bamford CR. Menstrual associated sleep disorder: an unusual hypersomniac variant associated with both menstruation and amenorrhea with a possible link to prolactin and metoclopramide. Sleep. 1993;16(5):484 486.

51. Rothstein JD, Guidotti A, Tinuper P, et al. Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor. Lancet. 1992;340(8826):1002 1004.

52. Lugaresi E, Montagna P, Tinuper P, et al. Endozepine stupor: recurring stupor linked to endozepine 4 accumulation. Brain. 1998;121(Pt 1):127 133.

53. Soriani S, Carrozzi M, De Carlo L, et al. Endozepine stupor in children. Cephalalgia. 1997;17(6):658 661.

54. Francisco GE, Ivanhoe CB. Successful treatment of post traumatic narcolepsy with methylphenidate: a case report. Am JPhys Med Rehabil. 1996;75(1):63 65.

55. Manni R, Tantara A. Evaluation of sleepiness in epilepsy. Clin Neurophysiol. 2000;111(Suppl 2): S111 114.

56. Toth LA, Opp MR. Sleep and infection. In: Lee Chiong TL, Sateia MJ, Carskadon MA, eds. Sleep medicine. Philadelphia, PA: Hanley & Belfus; 2002:77 83.

57. Guilleminault C, Mondini S. Mononucleosis and chronic daytime sleepiness: a long term follow up study. Arch Int Med. 1986;146(7):1333 1335.

58. Askenasy JJM. Sleep in parkinson's disease. Acta Neurol Scand. 1993;87(3):167 170.

59. Chokroverty S. Sleep and degenerative neurologic disorders. Neurol Clin. 1996;14(4):807 826.

60. Trenkwalder C. Sleep dysfunction in Parkinson's disease. Clin Neurosci. 1998;5(2):107 114.

61. George CFP. Neuromuscular disorders. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine, 3rd ed. Philadelphia, PA: WB Saunders; 2000:1087 1092.

62. Gibbs JW, Ciafaloni E, Radtke RA. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep. 2002;25(6): 662 665.

63. Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM. Clinical characteristics of fibrositis, I:

A "blinded" controlled study of symptoms and tender points. Arthritis Rheum. 1983;26(7):817 824.

64. Hyyppa MT, Kronhom E. Nocturnal motor activity in fibromyalgia patients with poor sleep quality.

J Psychosom Res. 1995;39(1):85 91.

65. Moldofsky H, Saskin P, Lue FA. Sleep and symptoms in fibrositis syndrome after a febrile illness.

J Rheumatol. 1988;15(11):1701 1704.

66. Moldofsky H, Lue FA, Smythe H. Alpha EEG sleep and morning symptoms of rheumatoid arthritis.

J Rheumatol. 1983;10(3):373 379.

67. Perlis ML, Giles DE, Bootzin RR, et al. Alpha sleep and information processing, perception of sleep, pain, and arousability in fibromyalgia. Int J Neurosci. 1997;89(3 4):265 280.

68. Moldolfsky H, Lue FA. The relationship of alpha delta EEG frequencies to pain and mood in "fibrositis" patients with chlorpromazine and L tryptophan. Electroencephalogr Clin Neurophysiol. 1980;50(1 2):71 80.

69. Yamashiro Y, Kryger MH. Sleep in heart failure. Sleep. 1993;16(6):513 523.

70. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation. 1998;97(21):2154 2159.

71. Brostrom A, Stromber A, Dahlsrom U, Fridland B. Sleep difficulties, daytime sleepiness, and health related quality of life in patients with chronic heart failure. J Cardiovasc Nurs. 2004;19(4):234 242.

72. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Social Sci. 2002; 54(9):1309 1321.

73. Portenoy RK, Tahler HT, Kombilth AB, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3(3):183 189.

74. Vena C, Parker K, Cunningham M, Clark J, McMillan S. Sleep wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol Nurs Forum. 2004;31(4):735 746.

75. Resta O, Paanacciulli N, Di Gioia G, et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis. 2004;14(5):248 253.

76. Blanco Perez JJ, Blanco Ramos MA, Zamarron Sanz C, et al. Acromegaly and sleep apnea. Arch Bronconeumol. 2004;40(8):355 359.

77. Rosenow F, Reuter S, Deuss U, et al. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf). 1996; 45(5):563 569.

78. Bjork S, Jonsson B, Westphal O, Levin JE. Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand Suppl. 1989;356:55 59.

79. Tylee A, Gastpar M, Lepine JP, Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee.

Int Clin Psychopharmacol. 1999;14(3):139 151.

80. Reynolds CF 3rd, Coble PA, Kupfer DJ, Holzer BC. Application of the multiple sleep latency test in disorders of excessive sleepiness. Electroencephalogr Clin Neurophysiol. 1982;53(4):443 452.

81. Liu X, Buysse DJ. Sleep and youth suicidal behavior: A neglected field. Curr Opin Psychiatry. 2006;19: 288 293.

82. Fava M. Daytime sleepiness and insomnia as correlates of depression. J Clin Psychiatry. 2004; 65:27 32.

83. Chellappa SL, Araujo JF. Sleep disorders and suicidal ideation in patients with depressive disorder. Psychiatry Res. 2007;153(2):131 136.

84. McCall WV, Harding D, O'Donovan C. Correlates of depressive symptoms in patients with obstructive sleep apnea. J Clin Sleep Med. 2006;2:424 426.

85. Sjostrom N, Waern M, Hetta J. Nightmares and sleep disturbances in relation to suicidality in suicide attempters. Sleep. 2007;30:91 95.

86. Fava M, Graves LM, Benazzi F, et al. A cross sectional study of the prevalence of cognitive and physical symptoms during long term antidepressant treatment. J Clin Psychiatry. 2006;67:1754 1759.

87. Williamson AM, Feyer AM. Moderate sleep deprivation produces impairments in cognitive and motor perfromance equivalent to legally prescribed levels of alcohol intoxication. Occup Environ Med. 2000;57:649 655.


Thomas D. Hurwitz and Carlos H. Schenck

Was this article helpful?

0 0


Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook

Post a comment